• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

d.perkins@unimelb.edu.au

Credentials


Position
Senior Research Fellow
Melbourne School of Population and Global Health - Centres and Institutes
Education
PhD
University of Melbourne
PhD
University of Melbourne
Graduate Diploma
University of Melbourne
Masters (Coursework & Research)
University of Melbourne
ORCID

0000-0002-2055-1649

Dr Daniel Perkins

Senior Research Fellow
Melbourne School of Population and Global Health

60 Scholarly works
2 Projects

HIGHLIGHTS

  • 2025

    Research grants (other domestic)

    Advancing Australian Innovation: Manufacturing Nasal Delivery Psychoactive Drugs for Unmet Mental Health Needs
  • 2023

    Journal article

    Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use
    DOI: 10.3389/fnins.2022.879221
  • 2022

    Journal article

    Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study
    DOI: 10.3389/fphar.2022.884703
  • 2022

    Research contracts (non-grants)

    Data Collection Medicinal Cannabis Use
  • 2022

    Journal article

    Psychedelic medicines for mood disorders: Current evidence and clinical considerations
    DOI: 10.1097/YCO.0000000000000759
  • 2021

    Journal article

    Legalization of Psychedelic Substances
    DOI: 10.1001/jama.2021.19372
  • 2021

    Journal article

    Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm
    DOI: 10.1177/0004867421998785
Daniel Perkins

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset
    DOI: 10.1080/02791072.2024.2424288
  • 2025

    Journal article

    Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study
    DOI: 10.1038/s41598-025-25767-x
  • 2025

    Journal article

    An international Delphi consensus for reporting of setting in psychedelic clinical trials
    DOI: 10.1038/s41591-025-03685-9
  • 2025

    Journal article

    A UHPLC-(ESI)MS/MS method for the determination of the psychedelic secondary metabolite mescaline in San Pedro (Trichocereus spp.) and its applicability for screening mescaline in other cacti varieties.
    DOI: 10.1016/j.forc.2025.100659
  • 2025

    Journal article

    Psilocybin-Assisted suppoRtive psychoTherapy in the treatment of prolonged Grief (PARTING) trial: Protocol for an open-label pilot trial for cancer-related bereavement
    DOI: 10.1136/bmjopen-2024-095992
  • 2025

    Journal article

    A new insight into ayahuasca's adverse effects: Reanalysis and perspectives on its mediating role in mental health from the Global Ayahuasca Survey (GAS)
    DOI: 10.1371/journal.pmen.0000097
  • 2025

    Journal article

    DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers
    DOI: 10.3389/fpsyt.2025.1545915
  • 2025

    Journal article

    Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption
    DOI: 10.1080/02791072.2025.2465800

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224